According to IMARC Group's report titled "India Women’s Health Devices Market Size, Share, Trends and Forecast by Application, Distribution Channel, and Region, 2026-2034", the report offers a comprehensive analysis of the industry, including industry growth, trends, share, and regional insights.
India's women's health devices market is expanding rapidly, driven by rising reproductive health awareness, growing gynecological condition prevalence, and accelerating innovation in wearable and AI-based diagnostics. According to IMARC Group, the market reached USD 6.5 Billion in 2025 and is projected to reach USD 15.7 Billion by 2034 at a CAGR of 9.89%.
- Periwinkle Technologies launched Smart Scope® CX in January 2025, an AI-driven device enabling single-visit cervical cancer screening with results in 30 seconds.
- Mankind Pharma completed its INR 13,768 crore acquisition of Bharat Serums and Vaccines in October 2024, strengthening its position in women's health and fertility treatments.
- Organon announced plans in January 2024 to launch the JADA System in India, a vacuum-induced device for managing postpartum hemorrhage.
- Telehealth-compatible devices and remote monitoring solutions are improving access to specialist care in Tier-2 and Tier-3 cities where gynecologists and endocrinologists are often unavailable.
- Device miniaturization — including portable ultrasound units, palm-sized ECG monitors, and home-based cervical screening kits — is expanding diagnostic access beyond hospital settings.
The Strategic Market Challenge: Navigating the Women's Health Devices Market in India
A critical, often overlooked challenge in India's women's health devices market is the persistent cultural stigma surrounding gynecological and reproductive health topics, which continues to limit open conversation and timely diagnosis despite growing awareness efforts. This taboo suppression slows adoption of preventive diagnostic devices, particularly in rural and semi-urban areas where social norms discourage women from openly discussing menstrual, fertility, or hormonal health concerns. Manufacturers and healthcare providers must navigate this sensitivity carefully, often requiring sustained community outreach investment before devices reach commercial scale in underserved geographies.
India's Strategic Vision for the Women's Health Devices Market:
Government and private sector initiatives are converging to expand preventive care access and normalize women's health technology adoption:
- Government-led community outreach programs and awareness campaigns are actively promoting reproductive health education, menstrual hygiene awareness, and preventive screening adoption across urban and rural India.
- Expansion of mobile health (mHealth) platforms is enabling women to proactively access health information and diagnostic solutions, particularly benefiting populations in underserved geographic regions.
- Rising investment in India's med-tech startup ecosystem, supported by international collaborations between domestic and overseas medical device manufacturers, is accelerating indigenous innovation in women-specific diagnostic technology.
- Strategic acquisitions like Mankind Pharma's purchase of Bharat Serums and Vaccines signal institutional consolidation aimed at strengthening domestic capability in women's health and fertility treatment infrastructure.
➤ Access Industry-Focused Insights and Future Forecasts - Request Sample Report
Why Invest in the India Women's Health Devices Market: Key Growth Drivers & ROI
- AI-driven diagnostics reducing access barriers: Periwinkle Technologies' Smart Scope® CX demonstrates how AI-powered, single-visit screening devices can reduce dependency on multi-visit diagnostic processes, directly improving access in low-resource settings. This single-visit model creates a scalable, high-volume revenue opportunity for manufacturers serving Tier-2 and Tier-3 markets.
- M&A activity validating sector consolidation value: Mankind Pharma's INR 13,768 crore acquisition of Bharat Serums and Vaccines reflects strong institutional conviction in women's health and fertility treatment infrastructure, signaling that scaled, vertically integrated players can command premium valuations in this category.
- Specialized device innovation addressing underserved conditions: Organon's JADA System for postpartum hemorrhage management addresses a critical, historically underserved maternal health emergency category. Devices targeting specific, high-severity conditions like PPH offer manufacturers differentiated positioning with strong clinical justification for premium pricing.
- Miniaturization enabling home healthcare expansion: Portable ultrasound devices, Bluetooth-connected pelvic floor trainers, and home-based cervical screening packs are shifting diagnostic revenue from purely hospital-based settings toward the growing home healthcare distribution channel, creating a new recurring revenue stream for device manufacturers.
India Women's Health Devices Market Trends & Future Outlook
- AI-based ovulation and fertility monitors will continue gaining adoption as women increasingly track conditions like PCOS, endometriosis, and menopause-related hormonal fluctuations from home.
- Smart menstrual health products, including intelligent period trackers and disposable menstrual cups, will see sustained demand growth as menstrual health awareness normalizes across socio-economic segments.
- Telehealth-compatible remote monitoring devices will expand specialist care access in Tier-2 and Tier-3 cities, enabling gynecologists and endocrinologists to deliver more responsive, data-driven care remotely.
- Device miniaturization will continue accelerating, with portable diagnostic tools increasingly replacing larger hospital-based equipment for routine screening and monitoring applications.
- Strategic M&A and consolidation activity, following Mankind Pharma's BSV acquisition, is likely to continue as larger pharmaceutical and medtech players seek scaled positions in the women's health category.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-womens-health-devices-market
Market Segmentation Breakdown:
Application Insights:
- Contraceptive Devices
- Mensuration Care
- Pregnancy and Nursing Care
- Others
Distribution Channel Insights:
- Hospitals and Clinics
- Home Healthcare
- Others
Regional Insights:
- North India
- South India
- East India
- West India
By the IMARC Group, the Top Competitive Landscape & their Positioning:
Covering an in-depth analysis of the competitive landscape, market structure, key player positioning, competitive dashboards, top winning strategies, and detailed profiles of all major industry participants you will gain access to all these exclusive insights within the full research report.
Regulatory Landscape & Policy Catalysts in India:
- Government Reproductive Health Awareness Programs: Community outreach programs and awareness campaigns led by government and private healthcare organizations are actively promoting reproductive health education, menstrual hygiene, and preventive screening across urban and rural populations.
- Mobile Health (mHealth) Platform Expansion: Government and private sector support for mHealth platform development is improving women's proactive access to health information and diagnostic solutions, particularly in underserved geographic regions.
- Medical Device Innovation and R&D Investment Support: Rising investment in India's med-tech startup ecosystem, supported by international collaborations, is fostering indigenous innovation in women-specific diagnostic and monitoring technology.
- Maternal Health Emergency Care Standards: Regulatory support for introducing specialized devices like the JADA System for postpartum hemorrhage management reflects growing institutional focus on addressing critical maternal health emergencies through advanced medical technology.
- Telemedicine Practice Guidelines: Regulatory frameworks supporting telehealth-compatible device usage are enabling remote monitoring and consultation models, expanding specialist care access in regions with limited on-ground gynecological and endocrinological infrastructure.
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
➤ Tailor the Research to Your Exact Business Needs - Request Customization:
Frequently Asked Questions (FAQs):
Q1: What is the current value and projected growth of the India Women's Health Devices Market?
According to IMARC Group, the India women's health devices market reached USD 6.5 Billion in 2025 and is projected to reach USD 15.7 Billion by 2034, growing at a CAGR of 9.89% over the forecast period 2026–2034.
Q2: Which application segments drive demand in this market?
The market is segmented into contraceptive devices, menstruation care, pregnancy and nursing care, and others. Menstruation care and pregnancy-related devices are seeing strong growth, driven by rising awareness and innovation in smart, connected health monitoring products.
Q3: Which distribution channels lead India's women's health devices market?
The market is segmented into hospitals and clinics, home healthcare, and others. Home healthcare is gaining significant traction as device miniaturization enables women to access diagnostic and monitoring tools without requiring hospital visits, particularly benefiting Tier-2 and Tier-3 city populations.
Q4: How is technology shaping the India women's health devices market?
AI-based diagnostics, device miniaturization, and telehealth-compatible remote monitoring are reshaping the market. Innovations like Periwinkle Technologies' Smart Scope® CX demonstrate how AI-driven, single-visit screening can reduce diagnostic barriers and improve access in low-resource settings.
Q5: What recent M&A activity signals investor confidence in this market?
Mankind Pharma's INR 13,768 crore acquisition of Bharat Serums and Vaccines in October 2024 reflects strong institutional confidence in India's women's health and fertility treatment sector, signaling continued consolidation potential as larger players seek scaled market positions.
Strategic Insight & Verdict
India's women's health devices market is moving from an underserved, awareness-constrained category toward a structurally significant healthcare segment backed by AI innovation, strategic M&A, and expanding home healthcare adoption. Cultural stigma reduction will remain key to unlocking full market potential. Based on segmental and deal activity data, we at IMARC Group have observed that companies investing in AI-driven diagnostics, home healthcare devices, and underserved maternal health categories are best positioned as the market scales toward USD 15.7 Billion by 2034.
Verified Data Source: India Women’s Health Devices Market Report by IMARC Group
Written by: Tarang Chauhan (Insights Specialist @ IMARC Group)
View my full professional profile and connect with me at [https://www.linkedin.com/in/tarang-chauhan-31a82b265] for exclusive market research insights and B2B growth strategies.
Comments